X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - New Drug Approvals - 01/Jul 23:07

FDA Approves Ahzantive (aflibercept-mrbb), a Biosimilar to Eylea

Planegg-Martinsried, Germany July 1, 2024 – Formycon AG (FSE: FYB, “Formycon”) and its licensing partner Klinge Biopharma GmbH (“Klinge”) jointly announce that the U.S. Food and Drug Administration (“FDA”)...

Articles similaires

Sorry! Image not available at this time

FDA Approves Otulfi (ustekinumab-aauz), a Biosimilar to Stelara

drugs.com - 30/Sep 21:09

September 30, 2024 -- Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies,...

Sorry! Image not available at this time

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 25/Sep 07:09

AUSTIN, TX, September 25, 2024– IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative...

Sorry! Image not available at this time

CD (Suzhou) Biopharma gets US FDA clearance to begin phase I trial of CD─001

pharmabiz.com - 23/Sep 14:54

CD(Suzhou) Biopharma, a rapidly advancing clinical─stage biotech company, has received clearance from the US Food and Drug Administration (FDA) for...

Sorry! Image not available at this time

UCB announces U.S. FDA approvals for Bimzelx (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis

drugs.com - 23/Sep 00:09

Brussels (Belgium), September 23, 2024 – 07:00 (CEST) – UCB, a global biopharmaceutical company, announced today that the U.S. Food and...

Sorry! Image not available at this time

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

drugs.com - 01/Oct 22:48

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with...

Sorry! Image not available at this time

FDA Approves Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

drugs.com - 27/Sep 04:09

PRINCETON, N.J.--(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 20/Sep 05:09

CELEBRATION, Fla., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare...

Sorry! Image not available at this time

FDA Approves Flyrcado (flurpiridaz F 18) Radioactive Diagnostic for Enhanced Diagnosis of Coronary Artery Disease

drugs.com - 27/Sep 20:09

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE) September 27, 2024 --GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves, Cobenfy, a New Kind of Drug for Schizophrenia

drugs.com - 27/Sep 10:09

FRIDAY, Sept. 27, 2024 -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food...

Sorry! Image not available at this time

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

drugs.com - 20/Sep 22:09

FRIDAY, Sept. 20, 2024 -- On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a...

Les derniers communiqués